US20010001813A1 - Vascular introducer sheath and hemostasis valve for use therewith - Google Patents

Vascular introducer sheath and hemostasis valve for use therewith Download PDF

Info

Publication number
US20010001813A1
US20010001813A1 US09/393,865 US39386599A US2001001813A1 US 20010001813 A1 US20010001813 A1 US 20010001813A1 US 39386599 A US39386599 A US 39386599A US 2001001813 A1 US2001001813 A1 US 2001001813A1
Authority
US
United States
Prior art keywords
gasket
hub
introducer sheath
cap
hemostasis valve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/393,865
Other versions
US6322541B2 (en
Inventor
Ronald L. West
Mark H. Van Diver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Scimed Life Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scimed Life Systems Inc filed Critical Scimed Life Systems Inc
Priority to US09/393,865 priority Critical patent/US6322541B2/en
Assigned to SCIMED LIFE SYSTEMS INC. reassignment SCIMED LIFE SYSTEMS INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WEST, RONALD L., VAN DIVER, MARK H.
Priority to DE2000616785 priority patent/DE60016785T2/en
Priority to PCT/US2000/020581 priority patent/WO2001017586A1/en
Priority to EP20000950838 priority patent/EP1225932B1/en
Publication of US20010001813A1 publication Critical patent/US20010001813A1/en
Application granted granted Critical
Publication of US6322541B2 publication Critical patent/US6322541B2/en
Assigned to BOSTON SCIENTIFIC SCIMED, INC. reassignment BOSTON SCIENTIFIC SCIMED, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: SCIMED LIFE SYSTEMS, INC.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
    • A61M39/0606—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof without means for adjusting the seal opening or pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
    • A61M2039/062—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof used with a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
    • A61M2039/0633—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof the seal being a passive seal made of a resilient material with or without an opening
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
    • A61M2039/0633—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof the seal being a passive seal made of a resilient material with or without an opening
    • A61M2039/064—Slit-valve
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/04—Access sites having pierceable self-sealing members
    • A61M39/045—Access sites having pierceable self-sealing members pre-slit to be pierced by blunt instrument
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00—Fluid handling
    • Y10T137/7722—Line condition change responsive valves
    • Y10T137/7837—Direct response valves [i.e., check valve type]
    • Y10T137/7879—Resilient material valve
    • Y10T137/788—Having expansible port

Definitions

  • the present invention generally relates to introducer sheaths for use in procedures requiring vascular access. More specifically, the present invention relates to hemostasis valves for use in such introducer sheaths.
  • Vascular introducer sheaths are well known components of vascular access systems which are used in a wide variety of diagnostic and therapeutic vascular procedures, such as angiography, angioplasty, thermolysis and embolization procedures.
  • Vascular access systems typically include an introducer sheath for use in combination with a guide wire and a dilator.
  • the introducer sheaths usually include a hemostatic or hemostasis valve which inhibits blood loss as guide wires, catheters and the like are introduced and manipulated in the vasculature via the sheath.
  • Davila '655 discloses a hemostasis valve including an inner housing, an end cap and a valve partition disposed between the inner housing and the end cap.
  • the end cap includes a compression ring having a diameter which is less than the diameter of the valve partition but greater than the diameter of the aperture in the end cap and the bore in the inner housing.
  • the compression ring causes the valve partition to bow outwardly. Purportedly, the bowing enhances the sealing of the slit in the valve partition.
  • the compression ring creates stress concentration points on the valve partition that may compromise the integrity of the valve partition. Furthermore, an excessive amount of compression must be applied by the compression ring against the valve partition to impart the bowing effect.
  • Paul '099 discloses a hemostatic valve including a gasket seal contained in a valve body and compressed therein by a cap connected to the valve body.
  • the valve body includes a valve seat, which in turn includes a flange and a series of annular recessed steps.
  • the flange serves to impart a concave shape to the gasket seal.
  • the series of annular steps serve to prevent the gasket seal from being displaced.
  • the hemostasis valve disclosed in Davila '655 suffers from the creation of stress concentration points imparted by the flange onto the valve gasket.
  • the annular steps recessed in the valve body may also create stress concentration points on the gasket seal. These stress concentration points may compromise the integrity of the gasket seal and also require an excessive amount of compression to impart the desired curved shape of the gasket seal.
  • the present invention overcomes these disadvantages by providing, in an exemplary embodiment, a vascular introducer sheath for use with a vascular access system.
  • the vascular introducer sheath includes a tubular shaft and a hemostasis valve assembly connected to the proximal end of the tubular shaft.
  • the hemostasis valve assembly includes a hub, a cap and a gasket disposed therebetween.
  • the gasket may be normally-flat and may have at least one normally-closed slit extending therethrough.
  • Both the hub and the cap include continuous contact surfaces facing the top and bottom surfaces of the gasket.
  • the continuous contact surfaces may be flat or gently curved, and may be smooth or include a means to grip the gasket. At least one of the contact surfaces forms a non-orthogonal angle with the longitudinal axis of the assembly to cause the gasket to become curved in response to compression between the hub and the cap.
  • the continuous contact surfaces uniformly distribute forces onto the perimeter of the gasket to avoid stress concentration points that may compromise gasket integrity.
  • the continuous contact surfaces increase the contact surface area and thereby reduce the amount of pressure necessary to impart the desired curved shape of the gasket.
  • FIG. 1 is a plan view of a vascular access system of the present invention including an introducer sheath and a dilator;
  • FIG. 2 is a cross-sectional side view of a hemostasis valve assembly of the present invention for use with the introducer sheath illustrated in FIG. 1;
  • FIG. 3 is a cross-sectional side view of an alternative hemostasis valve assembly of the present invention for use with the introducer sheath illustrated in FIG. 1;
  • FIG. 4 is a cross-sectional side view of another alternative hemostasis valve assembly of the present invention for use with the introducer sheath illustrated in FIG. 1;
  • FIG. 5 is an isometric perspective view of a gasket for use with any of the hemostasis valve assemblies of FIGS. 2 - 4 ;
  • FIGS. 6A and 6B are a cross-sectional views of the gasket illustrated in FIG. 5, shown in the normal (relaxed) state and the curved (compressed) state, respectively.
  • FIG. 1 illustrates a plan view of a vascular access system 10 in accordance with the present invention.
  • Vascular access system 10 includes two primary components, namely an introducer sheath 12 and a dilator 14 .
  • Introducer sheath 12 includes an elongate shaft 16 and a hemostasis valve assembly 18 .
  • the hemostasis valve assembly 18 is connected to the proximal end of the shaft 16 utilizing conventional techniques.
  • Hemostasis valve assembly 18 includes a hub, a cap and a gasket disposed therebetween as will be described in greater detail with reference to FIGS. 2 - 4 .
  • the hub of the hemostasis assembly 18 may include a side port 19 for connection to a flush or injection tube subassembly 20 .
  • the shaft 16 of the introducer 12 may have a size (outside diameter or profile) ranging from 4F to 9F, and a length ranging from 10 cm to 25 cm.
  • the distal tip of the elongate shaft 16 is preferably tapered to facilitate smooth insertion into the vascular system and smooth transition to the dilator 14 .
  • FIG. 2 illustrates a cross-sectional side view of the hemostasis valve assembly 18 for use with the introducer sheath 12 illustrated in FIG. 1.
  • the hemostasis valve assembly 18 includes a hub 22 , a cap 24 and a gasket 26 disposed therebetween.
  • the side port 19 of the hub 22 is not illustrated.
  • the hub 22 and the end cap 24 include a means for compressive connection therebetween, such as a snap-fit connection or a threaded connection, both of which are well-known in the art.
  • the hub 22 includes an inner lumen 28 extending therethrough, and the end cap 24 includes an aperture 30 extending therethrough.
  • the inner lumen 28 of the hub 22 is in fluid communication with the aperture 30 of the end cap 24 absent the gasket 26 , which includes one or more slits (not shown) discussed in more detail with reference to FIGS. 5, 6A and 6 B.
  • the hub 22 and the end cap 24 may have conventional dimensions and may be formed of conventional materials using known manufacturing techniques.
  • Hub 22 includes a continuous surface 32 which is in intimate contact with the bottom surface 34 of the gasket 26 .
  • the end cap 24 includes a continuous surface 36 in intimate contact with the top surface 38 of the gasket 26 .
  • the continuous contact surfaces 32 , 36 may be flat or gently curved and may be smooth or include a means to grip the gasket as described with reference to FIGS. 3 and 4.
  • Both the surface 32 of the hub 22 and the surface 36 of the end cap 24 define a line 41 that is tangent to the surface. If a curved surface is used, the tangent line 41 may be taken at the cross-sectional mid-point of the curved surface. Either the tangent line 41 of surface 32 or the tangent lines 41 of both surfaces 32 , 36 may be formed at an angle 40 with the longitudinal axis 42 of the assembly 18 .
  • the angle 40 is non-orthogonal (i.e. acute or obtuse) such that the gasket 26 becomes curved in response to compression between the hub 22 and the end cap 24 .
  • the continuous surfaces 32 , 36 which may be flat or gently curved, uniformly distribute forces onto the bottom and top surfaces 34 , 38 to avoid stress concentration points that may otherwise compromise the integrity of the gasket 26 .
  • the continuous contact surfaces 32 , 36 increase the contact surface area and thereby reduce the amount of pressure between the hub 22 and the end cap 24 necessary to impart the desired curved shape of the gasket 26 .
  • the continuous surfaces 32 , 36 form an acute angle 40 with the longitudinal axis 42 such that the top surface 38 of the gasket 26 assumes a convex shape.
  • the continuous surfaces 32 , 36 may form an obtuse angle 40 with the longitudinal axis 42 such that the top surface 38 assumes a concave shape.
  • both the surface 32 of the hub and the surface 36 of the end cap 24 may be formed at an angle 40 to cause the gasket 26 to assume a curved shape. If both surfaces 32 , 36 are formed at an angle 40 , the angles are preferably the same but may be different.
  • FIG. 3 illustrates a cross-sectional side view of an alternative hemostasis valve assembly 48 for use with the introducer sheath 12 illustrated in FIG. 1. Except as specifically described herein, hemostasis valve assembly 48 is the same in form and function as hemostasis valve 18 .
  • the end cap 24 includes a non-orthogonal continuous surface 36 as described previously, and a flat surface 37 that is orthogonal to the axis 42 . By providing an orthogonal flat surface 37 , the gasket 26 is less likely to be displaced from the recess formed between the hub 22 and the end cap 24 .
  • an orthogonal flat surface 37 and a non-orthogonal continuous surface 36 retains the gasket 26 between the hub 22 and the end cap 24 while guide wires, catheters and the like are advanced or retracted through the hemostasis valve assembly 48 .
  • FIG. 4 illustrates a cross-sectional side view of another alternative hemostasis valve assembly 58 for use with the introducer sheath illustrated in FIG. 1. Except as specifically described herein, hemostasis valve 58 is the same in form and function as hemostasis valve assembly 18 .
  • the gasket 26 is not illustrated in FIG. 4. It should be understood, however, that the gasket 26 is disposed between the hub 22 and the end cap 24 as described previously.
  • the continuous surfaces 32 , 36 of the hub 22 and the end cap 24 respectively, include an annular protrusion 44 to grip the gasket 26 .
  • Annular protrusion 44 preferably has a relatively low profile of less than approximately 0.010′′ to minimize or avoid creating stress concentration points on the gasket 26 . It is believed that the annular protrusions 44 do not contribute to curving the gasket 26 , but merely retain the gasket between the hub 22 and the cap 24 .
  • protrusions 44 and other suitable means for gripping the gasket 26 preferably do not significantly compromise the flatness or gentle curvature of the contact surfaces 32 , 36 engaging the gasket 26 .
  • protrusions and other means to grip the gasket 26 merely increase resistance to displacement of the gasket 26 relative to the hub 22 and the end cap 24 , but do not result in stress concentration or focal points that may otherwise compromise the integrity of the gasket 26 .
  • FIG. 5 illustrates an isometric perspective view of the gasket 26 for use with any of the hemostasis assemblies 18 , 48 , 58 illustrated in FIGS. 2 - 4 .
  • Gasket 26 includes a flat top surface 38 and a flat bottom surface 34 as described previously. Gasket 26 is normally flat such that the gasket 26 assumes a flat, disk shape when not in compression.
  • the gasket 26 may be formed of a variety of elastimeric materials such as PDMS, latex or other suitable material.
  • the gasket 26 has a durometer in the range of 15 A-50 A.
  • the gasket 26 thickness may range from approximately 0.045 to 0.075 inches and may have an outside diameter ranging from 0.050 to 0.150 inches to snugly fit in the recess of the cap 24 .
  • the gasket 26 may be punched out of a sheet of elastimeric material or molded using conventional techniques.
  • a slit 46 may be punched through the gasket 26 using a three-edged cutter or other suitable geometry, depending on the desired number and shape of the slits.
  • FIGS. 6A and 6B illustrate cross-sectional views of the gasket 26 shown in the normal (relaxed) state 26 A and the curved (compressed) state 26 B, respectively.
  • the normally flat gasket 26 A illustrated in FIG. 6A includes a slit 46 that is normally closed. Specifically, the slit 46 is normally closed at the top surface 38 and the bottom surface 34 of the gasket 26 such that a fluid tight seal is created along the entire length of the slit 46 .
  • the gasket 26 B assumes a curved shape, depending on the degree of compression and the angle 40 of the contact surfaces 32 , 36 .
  • the top surface 38 is shown to have a convex shape and the bottom surface 34 is shown to have a concave shape.
  • the surface that assumes the convex shape creates an opening 52 while an enhanced fluid tight seal 54 is created along the concave surface.
  • the opening 52 on the convex surface allows for easy insertion of a guide wire, catheter or the like, particularly when incorporated onto the top surface 38 of the gasket 26 .
  • the enhanced fluid tight seal 54 on the concave surface inhibits the egress of blood through the gasket 26 .
  • the size of the opening 52 and the amount of compression at the seal 54 depends in part on the degree of curvature of the gasket 26 .
  • the curvature of the gasket 26 may be adjusted by changing the angle 40 or the amount of compression to impart the desired size of the opening 52 and the desired tightness of the seal 54 .
  • the amount of curvature may be adjusted to affect device performance in terms of hemostasis (i.e., seal) and resistance (i.e., drag) to movement of devices passing therethrough.
  • the improved hemostasis valve assemblies provide continuous (e.g., flat or gently curved) contact surfaces between the gasket and the housing components (i.e., the hub and end cap).
  • the continuous contact surfaces distribute forces uniformly onto the perimeter of the gasket to avoid stress concentration points that may otherwise compromise gasket integrity.
  • the continuous contact surfaces increase the amount of contact area and thereby reduce the amount of pressure necessary to impart the desired curved shape of the gasket.

Abstract

A vascular introducer sheath including a tubular shaft and a hemostasis valve assembly connected to the proximal end thereof. The hemostasis valve assembly includes a hub, a cap and a normally-flat gasket disposed therebetween. Both the hub and the cap include continuous curved contact surfaces facing the top and bottom surfaces of the gasket. The continuous contact surfaces may be flat or gently curved and may be smooth or include a means to grip the gasket. At least one of the contact surfaces is formed at an angle to cause the gasket to become convex or concave in response to compression between the hub and the cap. The continuous contact surfaces uniformly distribute forces onto the perimeter of the gasket to avoid stress concentration points that may compromise gasket integrity. In addition, the continuous contact surfaces reduce the amount of pressure necessary to impart the curved shape of the gasket.

Description

    FIELD OF THE INVENTION
  • The present invention generally relates to introducer sheaths for use in procedures requiring vascular access. More specifically, the present invention relates to hemostasis valves for use in such introducer sheaths. [0001]
    • BACKGROUND OF THE INVENTION
  • Vascular introducer sheaths are well known components of vascular access systems which are used in a wide variety of diagnostic and therapeutic vascular procedures, such as angiography, angioplasty, thermolysis and embolization procedures. Vascular access systems typically include an introducer sheath for use in combination with a guide wire and a dilator. The introducer sheaths usually include a hemostatic or hemostasis valve which inhibits blood loss as guide wires, catheters and the like are introduced and manipulated in the vasculature via the sheath. [0002]
  • An example of a known hemostasis valve is disclosed in U.S. Pat. No. 5,520,655 to Davila et al. Davila '655 discloses a hemostasis valve including an inner housing, an end cap and a valve partition disposed between the inner housing and the end cap. The end cap includes a compression ring having a diameter which is less than the diameter of the valve partition but greater than the diameter of the aperture in the end cap and the bore in the inner housing. With this arrangement, the compression ring causes the valve partition to bow outwardly. Purportedly, the bowing enhances the sealing of the slit in the valve partition. However, the compression ring creates stress concentration points on the valve partition that may compromise the integrity of the valve partition. Furthermore, an excessive amount of compression must be applied by the compression ring against the valve partition to impart the bowing effect. [0003]
  • A similar hemostasis valve is disclosed in International Patent Publication No. WO 99/06099 to Paul. Paul '099 discloses a hemostatic valve including a gasket seal contained in a valve body and compressed therein by a cap connected to the valve body. The valve body includes a valve seat, which in turn includes a flange and a series of annular recessed steps. The flange serves to impart a concave shape to the gasket seal. The series of annular steps serve to prevent the gasket seal from being displaced. As with the hemostasis valve disclosed in Davila '655, the hemostasis valve disclosed in Paul '099 suffers from the creation of stress concentration points imparted by the flange onto the valve gasket. The annular steps recessed in the valve body, depending on the size, may also create stress concentration points on the gasket seal. These stress concentration points may compromise the integrity of the gasket seal and also require an excessive amount of compression to impart the desired curved shape of the gasket seal. [0004]
    • SUMMARY OF THE INVENTION
  • The present invention overcomes these disadvantages by providing, in an exemplary embodiment, a vascular introducer sheath for use with a vascular access system. The vascular introducer sheath includes a tubular shaft and a hemostasis valve assembly connected to the proximal end of the tubular shaft. The hemostasis valve assembly includes a hub, a cap and a gasket disposed therebetween. The gasket may be normally-flat and may have at least one normally-closed slit extending therethrough. [0005]
  • Both the hub and the cap include continuous contact surfaces facing the top and bottom surfaces of the gasket. The continuous contact surfaces may be flat or gently curved, and may be smooth or include a means to grip the gasket. At least one of the contact surfaces forms a non-orthogonal angle with the longitudinal axis of the assembly to cause the gasket to become curved in response to compression between the hub and the cap. The continuous contact surfaces uniformly distribute forces onto the perimeter of the gasket to avoid stress concentration points that may compromise gasket integrity. In addition, the continuous contact surfaces increase the contact surface area and thereby reduce the amount of pressure necessary to impart the desired curved shape of the gasket. [0006]
    • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a plan view of a vascular access system of the present invention including an introducer sheath and a dilator; [0007]
  • FIG. 2 is a cross-sectional side view of a hemostasis valve assembly of the present invention for use with the introducer sheath illustrated in FIG. 1; [0008]
  • FIG. 3 is a cross-sectional side view of an alternative hemostasis valve assembly of the present invention for use with the introducer sheath illustrated in FIG. 1; [0009]
  • FIG. 4 is a cross-sectional side view of another alternative hemostasis valve assembly of the present invention for use with the introducer sheath illustrated in FIG. 1; [0010]
  • FIG. 5 is an isometric perspective view of a gasket for use with any of the hemostasis valve assemblies of FIGS. [0011] 2-4; and
  • FIGS. 6A and 6B are a cross-sectional views of the gasket illustrated in FIG. 5, shown in the normal (relaxed) state and the curved (compressed) state, respectively. [0012]
    • DETAILED DESCRIPTION OF THE INVENTION
  • The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention. [0013]
  • Refer now to FIG. 1 which illustrates a plan view of a [0014] vascular access system 10 in accordance with the present invention. Vascular access system 10 includes two primary components, namely an introducer sheath 12 and a dilator 14. Introducer sheath 12 includes an elongate shaft 16 and a hemostasis valve assembly 18. The hemostasis valve assembly 18 is connected to the proximal end of the shaft 16 utilizing conventional techniques. Hemostasis valve assembly 18 includes a hub, a cap and a gasket disposed therebetween as will be described in greater detail with reference to FIGS. 2-4. The hub of the hemostasis assembly 18 may include a side port 19 for connection to a flush or injection tube subassembly 20. The shaft 16 of the introducer 12 may have a size (outside diameter or profile) ranging from 4F to 9F, and a length ranging from 10 cm to 25 cm. The distal tip of the elongate shaft 16 is preferably tapered to facilitate smooth insertion into the vascular system and smooth transition to the dilator 14.
  • Refer now to FIG. 2 which illustrates a cross-sectional side view of the [0015] hemostasis valve assembly 18 for use with the introducer sheath 12 illustrated in FIG. 1. As mentioned previously, the hemostasis valve assembly 18 includes a hub 22, a cap 24 and a gasket 26 disposed therebetween. For purposes of simplicity and clarity, the side port 19 of the hub 22 is not illustrated. Similarly, although not illustrated for purposes of simplicity and clarity, the hub 22 and the end cap 24 include a means for compressive connection therebetween, such as a snap-fit connection or a threaded connection, both of which are well-known in the art.
  • The [0016] hub 22 includes an inner lumen 28 extending therethrough, and the end cap 24 includes an aperture 30 extending therethrough. The inner lumen 28 of the hub 22 is in fluid communication with the aperture 30 of the end cap 24 absent the gasket 26, which includes one or more slits (not shown) discussed in more detail with reference to FIGS. 5, 6A and 6B. The hub 22 and the end cap 24 may have conventional dimensions and may be formed of conventional materials using known manufacturing techniques.
  • [0017] Hub 22 includes a continuous surface 32 which is in intimate contact with the bottom surface 34 of the gasket 26. Similarly, the end cap 24 includes a continuous surface 36 in intimate contact with the top surface 38 of the gasket 26. The continuous contact surfaces 32, 36 may be flat or gently curved and may be smooth or include a means to grip the gasket as described with reference to FIGS. 3 and 4.
  • Both the [0018] surface 32 of the hub 22 and the surface 36 of the end cap 24 define a line 41 that is tangent to the surface. If a curved surface is used, the tangent line 41 may be taken at the cross-sectional mid-point of the curved surface. Either the tangent line 41 of surface 32 or the tangent lines 41 of both surfaces 32, 36 may be formed at an angle 40 with the longitudinal axis 42 of the assembly 18. The angle 40 is non-orthogonal (i.e. acute or obtuse) such that the gasket 26 becomes curved in response to compression between the hub 22 and the end cap 24.
  • The [0019] continuous surfaces 32, 36, which may be flat or gently curved, uniformly distribute forces onto the bottom and top surfaces 34, 38 to avoid stress concentration points that may otherwise compromise the integrity of the gasket 26. In addition, the continuous contact surfaces 32, 36 increase the contact surface area and thereby reduce the amount of pressure between the hub 22 and the end cap 24 necessary to impart the desired curved shape of the gasket 26.
  • As illustrated, the [0020] continuous surfaces 32, 36 form an acute angle 40 with the longitudinal axis 42 such that the top surface 38 of the gasket 26 assumes a convex shape. Alternatively, the continuous surfaces 32, 36 may form an obtuse angle 40 with the longitudinal axis 42 such that the top surface 38 assumes a concave shape. As mentioned previously, it is only necessary that the surface 32 of the hub 22 is formed at an angle 40 with the longitudinal axis 42 in order to impart a curve on the gasket 26. However, both the surface 32 of the hub and the surface 36 of the end cap 24 may be formed at an angle 40 to cause the gasket 26 to assume a curved shape. If both surfaces 32, 36 are formed at an angle 40, the angles are preferably the same but may be different.
  • Refer now to FIG. 3 which illustrates a cross-sectional side view of an alternative [0021] hemostasis valve assembly 48 for use with the introducer sheath 12 illustrated in FIG. 1. Except as specifically described herein, hemostasis valve assembly 48 is the same in form and function as hemostasis valve 18. In this embodiment, the end cap 24 includes a non-orthogonal continuous surface 36 as described previously, and a flat surface 37 that is orthogonal to the axis 42. By providing an orthogonal flat surface 37, the gasket 26 is less likely to be displaced from the recess formed between the hub 22 and the end cap 24. Accordingly, the combination of an orthogonal flat surface 37 and a non-orthogonal continuous surface 36 retains the gasket 26 between the hub 22 and the end cap 24 while guide wires, catheters and the like are advanced or retracted through the hemostasis valve assembly 48.
  • Refer now to FIG. 4 which illustrates a cross-sectional side view of another alternative [0022] hemostasis valve assembly 58 for use with the introducer sheath illustrated in FIG. 1. Except as specifically described herein, hemostasis valve 58 is the same in form and function as hemostasis valve assembly 18. For purposes of simplicity and clarity, the gasket 26 is not illustrated in FIG. 4. It should be understood, however, that the gasket 26 is disposed between the hub 22 and the end cap 24 as described previously.
  • In this particular embodiment, the [0023] continuous surfaces 32, 36 of the hub 22 and the end cap 24, respectively, include an annular protrusion 44 to grip the gasket 26. Annular protrusion 44 preferably has a relatively low profile of less than approximately 0.010″ to minimize or avoid creating stress concentration points on the gasket 26. It is believed that the annular protrusions 44 do not contribute to curving the gasket 26, but merely retain the gasket between the hub 22 and the cap 24.
  • Those skilled in the art will recognize that other means may be employed to grip the [0024] gasket 26. For example, a series of small knobs or ridges may be utilized. Alternatively, the contact surfaces 32, 36 may be provided with a coating having a high coefficient of friction or other roughened surface treatment. However, it is to be understood that protrusions 44 and other suitable means for gripping the gasket 26 preferably do not significantly compromise the flatness or gentle curvature of the contact surfaces 32, 36 engaging the gasket 26. These protrusions and other means to grip the gasket 26 merely increase resistance to displacement of the gasket 26 relative to the hub 22 and the end cap 24, but do not result in stress concentration or focal points that may otherwise compromise the integrity of the gasket 26.
  • Refer now to FIG. 5 which illustrates an isometric perspective view of the [0025] gasket 26 for use with any of the hemostasis assemblies 18, 48, 58 illustrated in FIGS. 2-4. Gasket 26 includes a flat top surface 38 and a flat bottom surface 34 as described previously. Gasket 26 is normally flat such that the gasket 26 assumes a flat, disk shape when not in compression. The gasket 26 may be formed of a variety of elastimeric materials such as PDMS, latex or other suitable material. Preferably, the gasket 26 has a durometer in the range of 15 A-50 A. The gasket 26 thickness may range from approximately 0.045 to 0.075 inches and may have an outside diameter ranging from 0.050 to 0.150 inches to snugly fit in the recess of the cap 24. The gasket 26 may be punched out of a sheet of elastimeric material or molded using conventional techniques. A slit 46 may be punched through the gasket 26 using a three-edged cutter or other suitable geometry, depending on the desired number and shape of the slits. Those skilled in the art will recognize that the dimensions, materials and methods of manufacture may be readily modified without departing from the scope or spirit of the invention.
  • Refer now to FIGS. 6A and 6B which illustrate cross-sectional views of the [0026] gasket 26 shown in the normal (relaxed) state 26A and the curved (compressed) state 26B, respectively. The normally flat gasket 26A illustrated in FIG. 6A includes a slit 46 that is normally closed. Specifically, the slit 46 is normally closed at the top surface 38 and the bottom surface 34 of the gasket 26 such that a fluid tight seal is created along the entire length of the slit 46.
  • Upon compression, the gasket [0027] 26B assumes a curved shape, depending on the degree of compression and the angle 40 of the contact surfaces 32, 36. For purposes of illustration only, the top surface 38 is shown to have a convex shape and the bottom surface 34 is shown to have a concave shape. The surface that assumes the convex shape creates an opening 52 while an enhanced fluid tight seal 54 is created along the concave surface. The opening 52 on the convex surface allows for easy insertion of a guide wire, catheter or the like, particularly when incorporated onto the top surface 38 of the gasket 26. The enhanced fluid tight seal 54 on the concave surface inhibits the egress of blood through the gasket 26.
  • The size of the [0028] opening 52 and the amount of compression at the seal 54 depends in part on the degree of curvature of the gasket 26. The curvature of the gasket 26 may be adjusted by changing the angle 40 or the amount of compression to impart the desired size of the opening 52 and the desired tightness of the seal 54. Thus, the amount of curvature may be adjusted to affect device performance in terms of hemostasis (i.e., seal) and resistance (i.e., drag) to movement of devices passing therethrough.
  • From the foregoing, those skilled in the art will recognize that an improved vascular introducer sheath, and in particular an improved hemostasis valve assembly has been described. The improved hemostasis valve assemblies provide continuous (e.g., flat or gently curved) contact surfaces between the gasket and the housing components (i.e., the hub and end cap). The continuous contact surfaces distribute forces uniformly onto the perimeter of the gasket to avoid stress concentration points that may otherwise compromise gasket integrity. In addition, the continuous contact surfaces increase the amount of contact area and thereby reduce the amount of pressure necessary to impart the desired curved shape of the gasket. [0029]
  • Those skilled in the art will recognize that the present invention may be manifested in a variety of forms other than the specific embodiments described and contemplated herein. Accordingly, departures in form and detail may be made without departing from the scope and spirit of the present invention as described in the appended claims. [0030]

Claims (22)

What is claimed is:
1. A vascular introducer sheath for use with a vascular access system, the vascular introducer sheath comprising:
a tubular shaft having a proximal end and a distal end; and
a hemostasis valve assembly connected to the proximal end of the tubular shaft, the hemostasis valve assembly including a hub having a longitudinal axis and a continuous contact surface, a cap having a continuous contact surface, and a gasket disposed therebetween, wherein at least one of the contact surfaces forms a non-orthogonal angle with longitudinal axis to cause the gasket to become curved in response to compression between the hub and the cap.
2. A vascular introducer sheath as in
claim 1
, wherein the continuous contact surfaces are flat.
3. A vascular introducer sheath as in
claim 1
, wherein the continuous contact surfaces are gently curved.
4. A vascular introducer sheath as in
claim 1
, wherein the gasket is normally-flat.
5. A vascular introducer sheath as in
claim 4
, wherein the gasket has at least one slit extending therethrough, the slit being normally-closed when the gasket is flat.
6. A vascular introducer sheath as in
claim 1
, wherein both contact surfaces form a non-orthogonal angle with longitudinal axis to cause the gasket to become curved in response to compression between the hub and the cap.
7. A vascular introducer sheath as in
claim 6
, wherein the angle is acute.
8. A vascular introducer sheath as in
claim 7
, wherein a top surface of the gasket is convex.
9. A vascular introducer sheath as in
claim 6
, wherein the angle is obtuse.
10. A vascular introducer sheath as in
claim 9
, wherein a top surface of the gasket is concave.
11. A vascular introducer sheath as in
claim 1
, wherein at least one of the contact surfaces includes a means to retain the gasket between the hub and cap.
12. A vascular introducer sheath as in
claim 11
, wherein the retaining means comprises an orthogonal flat surface.
13. A hemostasis valve assembly for use with a vascular introducer sheath, the hemostasis valve assembly comprising:
a hub having a continuous contact surface and a longitudinal axis;
a cap co-axially disposed about the hub, the cap having a continuous contact surface; and
a gasket disposed between the hub and cap, the gasket having a top surface and a bottom surface, the top surface disposed adjacent the contact surface of the hub and the bottom surface disposed adjacent the contact surface of the cap, wherein the contact surface of the hub forms a non-orthogonal angle with longitudinal axis to cause the gasket to become curved in response to compression between the hub and the cap.
14. A hemostasis valve assembly as in
claim 13
, wherein the continuous contact surfaces are flat.
15. A hemostasis valve assembly as in
claim 13
, wherein the continuous contact surfaces are gently curved.
16. A hemostasis valve assembly as in
claim 13
, wherein the gasket is normally-flat.
17. A hemostasis valve assembly as in
claim 16
, wherein the gasket has at least one slit extending from the top surface to the bottom surface, the slit being normally-closed at both the top and bottom surfaces when the gasket is flat.
18. A hemostasis valve assembly as in
claim 13
, wherein the contact surface of the hub forms an acute angle with longitudinal axis to cause the top surface of the gasket to become convex in response to compression between the hub and the cap.
19. A hemostasis valve assembly as in
claim 13
, wherein the contact surface of the hub forms an obtuse angle with longitudinal axis to cause the top surface of the gasket to become concave in response to compression between the hub and the cap.
20. A hemostasis valve assembly as in
claim 13
, wherein both contact surfaces form a non-orthogonal angle with longitudinal axis to cause the gasket to become curved in response to compression between the hub and the cap.
21. A vascular introducer sheath as in
claim 13
, wherein at least one of the contact surfaces includes a means to retain the gasket between the hub and cap.
22. A vascular introducer sheath as in
claim 20
, wherein the retaining means comprises an orthogonal flat surface.
US09/393,865 1999-09-10 1999-09-10 Vascular introducer sheath and hemostasis valve for use therewith Expired - Lifetime US6322541B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US09/393,865 US6322541B2 (en) 1999-09-10 1999-09-10 Vascular introducer sheath and hemostasis valve for use therewith
DE2000616785 DE60016785T2 (en) 1999-09-10 2000-07-28 VASCULAR INTAKE SLEEVE AND HEMOSTATIC VALVE THEREFORE TO BE USED
PCT/US2000/020581 WO2001017586A1 (en) 1999-09-10 2000-07-28 Vascular introducer sheath and hemostasis valve for use therewith
EP20000950838 EP1225932B1 (en) 1999-09-10 2000-07-28 Vascular introducer sheath and hemostasis valve for use therewith

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/393,865 US6322541B2 (en) 1999-09-10 1999-09-10 Vascular introducer sheath and hemostasis valve for use therewith

Publications (2)

Publication Number Publication Date
US20010001813A1 true US20010001813A1 (en) 2001-05-24
US6322541B2 US6322541B2 (en) 2001-11-27

Family

ID=23556562

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/393,865 Expired - Lifetime US6322541B2 (en) 1999-09-10 1999-09-10 Vascular introducer sheath and hemostasis valve for use therewith

Country Status (4)

Country Link
US (1) US6322541B2 (en)
EP (1) EP1225932B1 (en)
DE (1) DE60016785T2 (en)
WO (1) WO2001017586A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050049628A1 (en) * 2002-08-29 2005-03-03 Medical Components, Inc. Releasably locking dilator and sheath assembly
JP2010201148A (en) * 2009-02-05 2010-09-16 Naigai Kasei Kk Medical cap and manufacturing method thereof
JP2010220758A (en) * 2009-03-23 2010-10-07 Naigai Kasei Kk Medical cap and method for manufacturing the same
JP2011036429A (en) * 2009-08-11 2011-02-24 Naigai Kasei Kk Medical cap, and method for manufacturing the same
US8403890B2 (en) 2004-11-29 2013-03-26 C. R. Bard, Inc. Reduced friction catheter introducer and method of manufacturing and using the same
US8608702B2 (en) 2007-10-19 2013-12-17 C. R. Bard, Inc. Introducer including shaped distal region
US8720065B2 (en) 2004-04-30 2014-05-13 C. R. Bard, Inc. Valved sheath introducer for venous cannulation
US8926564B2 (en) 2004-11-29 2015-01-06 C. R. Bard, Inc. Catheter introducer including a valve and valve actuator
US8932260B2 (en) 2004-11-29 2015-01-13 C. R. Bard, Inc. Reduced-friction catheter introducer and method of manufacturing and using the same
US9597483B2 (en) 2004-11-29 2017-03-21 C. R. Bard, Inc. Reduced-friction catheter introducer and method of manufacturing and using the same
US20180161566A1 (en) * 2015-08-17 2018-06-14 Goodman Co., Ltd. Valve Body for Medical Device, Medical Device, and Method for Manufacturing Valve Body for Medical Device
US10010344B2 (en) * 2015-07-13 2018-07-03 Dennis L Steffen Self-dilating catheter introducer with obturator and method of use

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9517622D0 (en) 1995-08-29 1995-11-01 Univ Edinburgh Regulation of intracellular glucocorticoid concentrations
EP0976365A1 (en) * 1998-07-27 2000-02-02 Osteo Ag Tibia nail for retrograde insertion
US7314477B1 (en) 1998-09-25 2008-01-01 C.R. Bard Inc. Removable embolus blood clot filter and filter delivery unit
US7537564B2 (en) 1998-12-01 2009-05-26 Atropos Limited Wound retractor device
US7559893B2 (en) 1998-12-01 2009-07-14 Atropos Limited Wound retractor device
US20040097996A1 (en) 1999-10-05 2004-05-20 Omnisonics Medical Technologies, Inc. Apparatus and method of removing occlusions using an ultrasonic medical device operating in a transverse mode
ATE415867T1 (en) 1999-10-14 2008-12-15 Atropos Ltd SURGICAL WOUND RETRACTOR
US6712789B1 (en) 2000-07-13 2004-03-30 Medamicus, Inc. Introducer having a movable valve assembly with removable side port
EP1326524B1 (en) 2000-10-19 2010-09-01 Applied Medical Resources Corporation Surgical access apparatus and method
US6776774B2 (en) * 2001-07-16 2004-08-17 Scimed Life Systems, Inc. Hemostasis gasket valve
CA2457687C (en) 2001-08-14 2013-01-15 Applied Medical Resources Corporation Access sealing apparatus and method
US6958037B2 (en) 2001-10-20 2005-10-25 Applied Medical Resources Corporation Wound retraction apparatus and method
WO2003070313A1 (en) * 2002-02-19 2003-08-28 Medamicus, Inc. Composite stasis valve
US9204956B2 (en) 2002-02-20 2015-12-08 C. R. Bard, Inc. IVC filter with translating hooks
US20030163147A1 (en) * 2002-02-22 2003-08-28 Rabiner Robert A. Apparatus and method for using a vascular introducer with an ultrasonic probe
US7650887B2 (en) 2002-06-05 2010-01-26 Applied Medical Resources Corporation Wound retractor
US9271753B2 (en) 2002-08-08 2016-03-01 Atropos Limited Surgical device
DE60314464T2 (en) 2002-09-19 2008-02-14 Atropos Ltd., Bray SURGICAL WOUND RETRACTOR
US20050020884A1 (en) 2003-02-25 2005-01-27 Hart Charles C. Surgical access system
US7435236B2 (en) 2003-06-27 2008-10-14 Navilyst Medical, Inc. Pressure actuated valve with improved biasing member
WO2005013803A2 (en) 2003-08-06 2005-02-17 Applied Medical Resources Corporation Surgical device with tack-free gel and method of manufacture
US7163510B2 (en) 2003-09-17 2007-01-16 Applied Medical Resources Corporation Surgical instrument access device
US7794414B2 (en) 2004-02-09 2010-09-14 Emigrant Bank, N.A. Apparatus and method for an ultrasonic medical device operating in torsional and transverse modes
US7594910B2 (en) 2004-03-18 2009-09-29 C. R. Bard, Inc. Catheter connector
US7594911B2 (en) 2004-03-18 2009-09-29 C. R. Bard, Inc. Connector system for a proximally trimmable catheter
US8083728B2 (en) 2004-03-18 2011-12-27 C. R. Bard, Inc. Multifunction adaptor for an open-ended catheter
US7854731B2 (en) 2004-03-18 2010-12-21 C. R. Bard, Inc. Valved catheter
US7377915B2 (en) 2004-04-01 2008-05-27 C. R. Bard, Inc. Catheter connector system
US7704267B2 (en) 2004-08-04 2010-04-27 C. R. Bard, Inc. Non-entangling vena cava filter
JP2008515523A (en) 2004-10-11 2008-05-15 アトロポス・リミテッド Instrument access device
US7794473B2 (en) 2004-11-12 2010-09-14 C.R. Bard, Inc. Filter delivery system
US8267954B2 (en) 2005-02-04 2012-09-18 C. R. Bard, Inc. Vascular filter with sensing capability
JP5102201B2 (en) 2005-05-12 2012-12-19 シー・アール・バード・インコーポレーテッド Removable embolic clot filter
US7875019B2 (en) 2005-06-20 2011-01-25 C. R. Bard, Inc. Connection system for multi-lumen catheter
JP2009501045A (en) 2005-07-15 2009-01-15 アトロポス・リミテッド Wound retractor
JP4851522B2 (en) 2005-08-09 2012-01-11 シー・アール・バード・インコーポレーテッド Insertion type thrombus filter and delivery system
EP1933730B1 (en) 2005-10-14 2010-02-24 Applied Medical Resources Corporation Split hoop wound retractor with gel pad
CA2940038C (en) 2005-11-18 2018-08-28 C.R. Bard, Inc. Vena cava filter with filament
EP1954343B1 (en) 2005-12-02 2012-01-18 C.R.Bard, Inc. Pressure-activated proximal valves
WO2007133366A2 (en) 2006-05-02 2007-11-22 C. R. Bard, Inc. Vena cava filter formed from a sheet
CA2655158A1 (en) 2006-06-05 2007-12-13 C.R. Bard Inc. Embolus blood clot filter utilizable with a single delivery system or a single retrieval system in one of a femoral or jugular access
JP4994775B2 (en) 2006-10-12 2012-08-08 日本コヴィディエン株式会社 Needle point protector
JP5441890B2 (en) 2007-05-11 2014-03-12 アプライド メディカル リソーシーズ コーポレイション Surgical retractor with gel pad
JP5231534B2 (en) 2007-05-11 2013-07-10 アプライド メディカル リソーシーズ コーポレイション Surgical retractor
US8657740B2 (en) 2007-06-05 2014-02-25 Atropos Limited Instrument access device
WO2008149332A1 (en) 2007-06-05 2008-12-11 Atropos Limited An instrument access device
EP3456372A1 (en) * 2007-06-22 2019-03-20 Medical Components, Inc. Tearaway sheath assembly with hemostasis valve
WO2009038727A1 (en) * 2007-09-18 2009-03-26 Medical Components, Inc. Tearaway sheath assembly with split hemostasis valve
WO2009094476A1 (en) 2008-01-22 2009-07-30 Applied Medical Resources Corporation Surgical instrument access device
WO2009114456A1 (en) * 2008-03-14 2009-09-17 Medical Components, Inc. Tearaway introducer sheath with hemostasis valve
US8257321B2 (en) * 2008-05-21 2012-09-04 Navilyst Medical, Inc. Pressure activated valve for high flow rate and pressure venous access applications
EP3275386B1 (en) 2008-10-13 2024-01-03 Applied Medical Resources Corporation Single port access system
US8375955B2 (en) 2009-02-06 2013-02-19 Atropos Limited Surgical procedure
US8337484B2 (en) 2009-06-26 2012-12-25 C. R. Band, Inc. Proximally trimmable catheter including pre-attached bifurcation and related methods
US8007468B2 (en) 2009-07-13 2011-08-30 Navilyst Medical, Inc. Method to secure an elastic component in a valve
ES2717424T3 (en) 2009-07-29 2019-06-21 Bard Inc C R Tubular filter
WO2011033495A1 (en) 2009-09-17 2011-03-24 Atropos Limited An instrument access device
US9289200B2 (en) 2010-10-01 2016-03-22 Applied Medical Resources Corporation Natural orifice surgery system
US9289115B2 (en) 2010-10-01 2016-03-22 Applied Medical Resources Corporation Natural orifice surgery system
US8486024B2 (en) 2011-04-27 2013-07-16 Covidien Lp Safety IV catheter assemblies
ES2822115T3 (en) 2011-05-10 2021-04-29 Applied Med Resources Wound retractor device
EP2730308B1 (en) * 2011-07-04 2016-12-28 Terumo Kabushiki Kaisha Introducer sheath
EP2760520A1 (en) 2011-09-26 2014-08-06 Covidien LP Safety catheter
WO2013048768A1 (en) 2011-09-26 2013-04-04 Covidien Lp Safety iv catheter and needle assembly
WO2013056223A1 (en) 2011-10-14 2013-04-18 Covidien Lp Safety iv catheter assembly
KR102300866B1 (en) 2013-03-15 2021-09-13 어플라이드 메디컬 리소시스 코포레이션 Mechanical gel surgical access device
JP6417705B2 (en) * 2014-05-13 2018-11-07 ニプロ株式会社 Hub with valve
ES2703184T3 (en) 2014-07-18 2019-03-07 Applied Med Resources Method for manufacturing gels that have permanent tack-free coatings
EP4101405A1 (en) 2014-08-15 2022-12-14 Applied Medical Resources Corporation Natural orifice surgery system
CA2967015C (en) 2014-11-07 2023-02-28 C.R. Bard, Inc. Connection system for tunneled catheters
EP3223718A2 (en) 2014-11-25 2017-10-04 Applied Medical Resources Corporation Circumferential wound retraction with support and guidance structures
ES2836282T3 (en) 2015-09-15 2021-06-24 Applied Med Resources Surgical robotic access system
EP3359057B1 (en) 2015-10-07 2023-07-05 Applied Medical Resources Corporation Wound retractor with multi-segment outer ring
CA3036192A1 (en) 2016-09-12 2018-03-15 Applied Medical Resources Corporation Surgical robotic access system for irregularly shaped robotic actuators and associated robotic surgical instruments
US10737085B2 (en) * 2017-05-05 2020-08-11 Greatbatch Ltd. Medical device with hemostatic valve
EP3672682B1 (en) 2017-08-23 2024-04-03 C. R. Bard, Inc. Catheter assemblies and methods thereof

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000739A (en) 1975-07-09 1977-01-04 Cordis Corporation Hemostasis cannula
US4254773A (en) 1978-11-24 1981-03-10 Medex Inc. Swivel coupling for a catheterization system
US4430081A (en) 1981-01-06 1984-02-07 Cook, Inc. Hemostasis sheath
US4366817A (en) 1981-05-26 1983-01-04 Burron Medical Inc. Winged IV catheter
US4436519A (en) 1981-05-28 1984-03-13 Argon Medical Corp. Removable hemostasis valve
US4424833A (en) 1981-10-02 1984-01-10 C. R. Bard, Inc. Self sealing gasket assembly
US4929235A (en) 1985-07-31 1990-05-29 Universal Medical Instrument Corp. Self-sealing percutaneous tube introducer
US5251873B1 (en) 1992-06-04 1995-05-02 Vernay Laboratories Medical coupling site.
US4798594A (en) 1987-09-21 1989-01-17 Cordis Corporation Medical instrument valve
US4895565A (en) 1987-09-21 1990-01-23 Cordis Corporation Medical instrument valve
US5059186A (en) 1988-03-07 1991-10-22 Vitaphore Corporation Percutaneous access device
US5098393A (en) 1988-05-31 1992-03-24 Kurt Amplatz Medical introducer and valve assembly
US4874378A (en) 1988-06-01 1989-10-17 Cordis Corporation Catheter sheath introducer
US4944729A (en) 1988-08-29 1990-07-31 Shiley, Inc. Femoral arterial cannula
US4950257A (en) 1988-09-15 1990-08-21 Mallinckrodt, Inc. Catheter introducer with flexible tip
US5000745A (en) 1988-11-18 1991-03-19 Edward Weck Incorporated Hemostatis valve
US4946133A (en) 1988-11-21 1990-08-07 Schneider (U.S.A.) Inc., A Pfizer Co. Hemostasis valve
US5499975A (en) 1989-01-31 1996-03-19 Cook Incorporated Smooth transitioned dilator-sheath assembly and method
US5045065A (en) 1989-03-20 1991-09-03 Raulerson J Daniel Catheter introduction syringe
JPH03242153A (en) 1990-02-13 1991-10-29 Daig Corp Cylindrical plug to seal induction steel wire
US5137519A (en) 1990-03-12 1992-08-11 Cordis Corporation Catheter retention collar and support
US5114408A (en) 1990-10-18 1992-05-19 Daig Corporation Universal hemostasis valve having improved sealing characteristics
JPH04170966A (en) 1990-11-01 1992-06-18 Nippon Sherwood Kk Valvular body for catheter introducer blood stop valve
US5242410A (en) 1991-04-15 1993-09-07 University Of Florida Wireless high flow intravascular sheath introducer and method
US5092857A (en) 1991-05-17 1992-03-03 Fleischhacker John J Hemostasis valve having support shoulders
US5154701A (en) 1991-06-26 1992-10-13 Adam Spence Corporation Hemostasis valve
DE4127628C1 (en) 1991-08-21 1992-07-23 Vygon Gmbh & Co Kg, 5100 Aachen, De
US5188607A (en) 1991-11-12 1993-02-23 Thomas Wu Valve catheter connector assembly
US5300033A (en) 1992-07-09 1994-04-05 Unisurge, Inc. Introducer assembly and valve construction for use therein
US5267966A (en) 1992-09-28 1993-12-07 Cook Incorporated Hemostasis cannula and method of making a valve for same
US5234410A (en) 1992-10-23 1993-08-10 Vlv Associates Catheter assembly
US5330435A (en) 1993-04-08 1994-07-19 Vaillancourt Vincent L Valve for a catheter assembly
US5613956A (en) 1993-05-07 1997-03-25 C. R. Bard, Inc. Catheter introducer
US5549576A (en) 1993-05-07 1996-08-27 C. R. Bard, Inc. Vascular introducer valve with proximal self-lubrication
US5350363A (en) 1993-06-14 1994-09-27 Cordis Corporation Enhanced sheath valve
US5538505A (en) 1993-06-14 1996-07-23 Cordis Corporation Hemostasis valve for catheter introducer having thickened central partition section
US5944697A (en) 1994-05-31 1999-08-31 Universal Medical Instrument Corp. Percutaneous catheter introducer
US5520655A (en) * 1994-07-15 1996-05-28 Cordis Corporation Catheter hemostasis valve
US5599305A (en) 1994-10-24 1997-02-04 Cardiovascular Concepts, Inc. Large-diameter introducer sheath having hemostasis valve and removable steering mechanism
US5807350A (en) * 1995-11-03 1998-09-15 Cordis Corporation Kink resistant catheter sheath introducer
US5762630A (en) 1996-12-23 1998-06-09 Johnson & Johnson Medical, Inc. Thermally softening stylet
US5911710A (en) 1997-05-02 1999-06-15 Schneider/Namic Medical insertion device with hemostatic valve
US6416499B2 (en) 1997-07-30 2002-07-09 Cook Incorporated Medical fluid flow control valve
NL1007997C2 (en) 1998-01-09 1999-07-12 Cordis Europ Device for inserting an elongated medical device.

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7422571B2 (en) 2002-08-29 2008-09-09 Medical Components, Inc. Releasably locking dilator and sheath assembly
US9248261B2 (en) 2002-08-29 2016-02-02 Medical Components, Inc. Releasably locking dilator and sheath assembly
US20050049628A1 (en) * 2002-08-29 2005-03-03 Medical Components, Inc. Releasably locking dilator and sheath assembly
US8720065B2 (en) 2004-04-30 2014-05-13 C. R. Bard, Inc. Valved sheath introducer for venous cannulation
US10307182B2 (en) 2004-04-30 2019-06-04 C. R. Bard, Inc. Valved sheath introducer for venous cannulation
US9108033B2 (en) 2004-04-30 2015-08-18 C. R. Bard, Inc. Valved sheath introducer for venous cannulation
US9078998B2 (en) 2004-11-29 2015-07-14 C. R. Bard, Inc. Catheter introducer including a valve and valve actuator
US9597483B2 (en) 2004-11-29 2017-03-21 C. R. Bard, Inc. Reduced-friction catheter introducer and method of manufacturing and using the same
US8926564B2 (en) 2004-11-29 2015-01-06 C. R. Bard, Inc. Catheter introducer including a valve and valve actuator
US8932260B2 (en) 2004-11-29 2015-01-13 C. R. Bard, Inc. Reduced-friction catheter introducer and method of manufacturing and using the same
US8403890B2 (en) 2004-11-29 2013-03-26 C. R. Bard, Inc. Reduced friction catheter introducer and method of manufacturing and using the same
US9101737B2 (en) 2004-11-29 2015-08-11 C. R. Bard, Inc. Reduced friction catheter introducer and method of manufacturing and using the same
US10398879B2 (en) 2004-11-29 2019-09-03 C. R. Bard, Inc. Reduced-friction catheter introducer and method of manufacturing and using the same
US9283351B2 (en) 2004-11-29 2016-03-15 C. R. Bard, Inc. Reduced friction catheter introducer and method of manufacturing and using the same
US9278188B2 (en) 2004-11-29 2016-03-08 C. R. Bard, Inc. Catheter introducer including a valve and valve actuator
US8608702B2 (en) 2007-10-19 2013-12-17 C. R. Bard, Inc. Introducer including shaped distal region
JP2010201148A (en) * 2009-02-05 2010-09-16 Naigai Kasei Kk Medical cap and manufacturing method thereof
JP2010220758A (en) * 2009-03-23 2010-10-07 Naigai Kasei Kk Medical cap and method for manufacturing the same
JP2011036429A (en) * 2009-08-11 2011-02-24 Naigai Kasei Kk Medical cap, and method for manufacturing the same
US10010344B2 (en) * 2015-07-13 2018-07-03 Dennis L Steffen Self-dilating catheter introducer with obturator and method of use
US20180161566A1 (en) * 2015-08-17 2018-06-14 Goodman Co., Ltd. Valve Body for Medical Device, Medical Device, and Method for Manufacturing Valve Body for Medical Device

Also Published As

Publication number Publication date
EP1225932B1 (en) 2004-12-15
DE60016785T2 (en) 2005-12-15
EP1225932A1 (en) 2002-07-31
DE60016785D1 (en) 2005-01-20
US6322541B2 (en) 2001-11-27
EP1225932A4 (en) 2003-01-22
WO2001017586A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
US6322541B2 (en) Vascular introducer sheath and hemostasis valve for use therewith
EP1409069B1 (en) Hemostasis gasket valve
US5006113A (en) Hemostasis cannula
US6551283B1 (en) Hemostasis valve
EP1250171B1 (en) Hemostasis valve
US6142981A (en) Hemostasis valve
US5273546A (en) Hemostasis valve
US5409463A (en) Catheter introducer with lubrication means
EP1359968B1 (en) Hemostasis valve
US8753317B2 (en) Hemostasis cannula
CA2003222C (en) Hemostasis valve
US5176652A (en) Hemostasis valve
US5538505A (en) Hemostasis valve for catheter introducer having thickened central partition section
US20040127855A1 (en) Hemostasis valve
US7335182B1 (en) Valved connector with closure operated by axial movement of the valve
WO1993002734A1 (en) Hemostasis valve
JPH0433238B2 (en)
AU650357B2 (en) Hemostasis cannula
EP0868203B1 (en) Hemostasis cannula
JP3486353B2 (en) Medical valve
JPH02948B2 (en)

Legal Events

Date Code Title Description
AS Assignment

Owner name: SCIMED LIFE SYSTEMS INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WEST, RONALD L.;VAN DIVER, MARK H.;REEL/FRAME:010381/0327;SIGNING DATES FROM 19990924 TO 19991012

STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868

Effective date: 20050101

Owner name: BOSTON SCIENTIFIC SCIMED, INC.,MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868

Effective date: 20050101

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12